Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Approval

Clinical Trials

Cellular Intelligence Takes Global Rights to Novo Nordisk’s Parkinson’s Cell Therapy

The transfer puts an AI-focused biotech in charge of a fast-track Parkinson’s cell therapy.

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

For Third Time, FDA Rejects Aldeyra’s Dry-Eye Drug Reproxalap Over Efficacy

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

EU Approves Donanemab as Second Alzheimer’s Antibody Under Tight Conditions

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

Neumora’s Depression Drug Fails to Meet Goals in Key Phase 3 Trial